Advertisement

Glucagon and Somatostatin

  • Roger H. Unger

Abstract

The primary structure of true glucagon, the biologically active 3485-molecular-weight polypeptide, is identical in all mammalian species thus far studied, with the exception of the guinea pig. Porcine (Bromer et al., 1957), bovine (Bromer et al., 1971), and human (Thomsen et al., 1972) glucagons have identical sequences, and it is likely that rabbit (Sundby and Markussen, 1972), camel, and rat (Sundby and Markussen, 1971) glucagons are also identical. The guinea pig glucagon, however, has a molecular weight of 4000–5000 and appears to differ from porcine glucagon (Sundby, 1976).

Keywords

Adenosine Pancreatitis Ketone Pyruvate Prostaglandin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguilar-Parada, E., Eisentraut, A. M., and Unger, R. H., 1969, Pancreatic glucagon secretion in normal and diabetic subjects, Amer. J. Med. Sci. 257:415.PubMedGoogle Scholar
  2. Arimura, A., Sato, H., Dupont, A., Nishi, N., and Schally, A. V., 1975, Somatostatin: Abundance of immunoreactive hormone in rat stomach and pancreas, Science 189:1007.PubMedGoogle Scholar
  3. Aronoff, S. L., Bennett, P. H., Rushforth, N. B., Miller, M., and Unger, R. H., 1976a, Arginine stimulated hyperglucagonemia in diabetic Pima Indians, Diabetes 25:404.Google Scholar
  4. Aronoff, S. L., Bennett, P. H., Rushforth, N. B., Miller, M., and Unger, R. H., 1976b, Normal glucagon response to arginine infusion in “prediabetic” Plina Indians, J.Clin. Endocrinol. Metab. 43:279.Google Scholar
  5. Ashby, J. P., and Speake, R. N., 1975, Insulin and glucagon secretion from isolated islets of Langerhans. The effects of calcium ionophores, Biochem. J. 150:89.PubMedGoogle Scholar
  6. Assan, R., 1972, In vivo metabolism of glucagon, in: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications (P. J. Lefebvre and R. H. Unger, eds.), pp. 47–59, Pergamon Press, Oxford.Google Scholar
  7. Assan, R., and Slusher, N., 1972, Structure/function and structure/immunoreac-tivity relationships of the glucagon molecule and related synthetic peptides, Diabetes 21:843.PubMedGoogle Scholar
  8. Assan, R., Hautecouverture, G., Guillemant, S., Douchy, F., Protin, P., and Derot, M., 1969, Evolution de parametres hormonaux (glucagon, Cortisol, hormone somatotrope) et energetiques (glucose, acides gras glycerol libre) dans dix acido-cetoses diabetiques graves traitees, Pathol. Biol. 17:1095.PubMedGoogle Scholar
  9. Baetens, D., Coleman, D. L., and Orci, L., 1976a, Islet cell population in ob/ob and db/db mice, Diabetes 25:344.Google Scholar
  10. Baetens, D., Rufener, C., Srikant, C. B., Dobbs, R., Unger, R., and Orci, L., 1976b, Identification of glucagon-producing cells (A-cells) in dog gastric mucosa, J. Cell Biol 69:455.Google Scholar
  11. Barden, N., Lavoie, M., Alvarado-Urbina, G., Cote, J.-P., and Dupont, A., 1977, A physiologic role of somatostatin in the control of insulin and glucagon secretion, Fed. Proc. Fed. Amer. Soc. Exp. Biol. 36:298.Google Scholar
  12. Barnes, A. J., and Bloom, S. R., 1976, Pancreatectomized man: A model for diabetes without glucagon, Lancet 1:219.PubMedGoogle Scholar
  13. Bhathena, S. J., Perrino, P. V., Voyles, N. R., Smith, S. S., Wilkins, S. D., Coy, D. H., Schally, A. V., and Recant, L., 1976, Reversal of somatostatin inhibition of insulin and glucagon secretion, Diabetes 25:1031.PubMedGoogle Scholar
  14. Bilbrey, G. L., Faloona, G. R., White, M. C., and Knochel, J. P., 1974, Hyperglucagonemia of renal failure,J. Clin, Invest. 53:841.Google Scholar
  15. Bilheimer, D. W., Goldstein, J. L., Grundy, S. M., and Brown, M. S., 1975, Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia, J. Clin. Invest. 56:1420.PubMedGoogle Scholar
  16. Blackard, W. G., Nelson, N. C., and Andrews, S. S., 1974, Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions, Diabetes 23:199.PubMedGoogle Scholar
  17. Blair, J. B., Cimbala, M. A., Foster, J. L., and Morgan, R. A., 1976, Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3′-5′-monophosphate, and insulin in the perfused rat liver,J. Biol. Chem. 251:3756.PubMedGoogle Scholar
  18. Blazquez, E., Muñoz-Barragan, L., Patton, G. S., Orci, L., Dobbs, R. E., and Unger, R. H., 1976, Gastric A-cell function in insulin-deprived depancreatized dogs, Endocrinology 99:1182.PubMedGoogle Scholar
  19. Blazquez, E., Muñoz-Barragan, L., Patton, G. S., Dobbs, R. E., and Unger, R. H., 1977, Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan diabetic dogs, J. Lab. Clin. Med. 89:971.Google Scholar
  20. Bloom, S. R., Mortimer, C. H., Thorner, M. O., Besser, G. M., Hall, R., Gomez-Pan, A., Roy, V. M., Russell, R. C. G., Coy, D. H., Kastin, A. J., and Schally, A. V., 1974, Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone, Lancet 2:1106.PubMedGoogle Scholar
  21. Bloom, S. R., Ralphs, D. N., Besser, G. M., Hall, R., Coy, D. H., Kastin, A. J., and Schally, A. V., 1975, Effect of somatostatin on motilin levels and gastric emptying, Gut 16:834.PubMedGoogle Scholar
  22. Blundell, T. L., Dockerill, S., Sasaki, K., Tickle, I. J., and Wood, S. P., 1976, The relation of structure to storage and receptor binding of glucagon, Metabolism 25(Suppl.):1331.PubMedGoogle Scholar
  23. Boden, G., Sivitz, M. C., Owen, O. E., Essakoumar, N., and Lauder, J. H., 1975, Somatostatin suppresses secretin and pancreatic exocrine secretion, Science 190:163.PubMedGoogle Scholar
  24. Boden, G., Jacoby, H. I., and Staus, A., 1976, Somatostatin interacts with basal and carbachol stimulated antral and duodenal motility, Gastroenterology 70:961.Google Scholar
  25. Böttger, L., Schlein, E., Faloona, G. R., Knochel, J. P., and Unger, R. H., 1972, The effect of exercise on glucagon secretion,J. Clin. Endocrinol. Metab. 35:117.PubMedGoogle Scholar
  26. Braaten, J. T., Faloona, G. R., and Unger, R. H., 1974, The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes, J. Clin. Invest. 53:1017.PubMedGoogle Scholar
  27. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R., 1973, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science 179:77.PubMedGoogle Scholar
  28. Brockman, R. P., Bergman, E. N., Joo, P. K., and Manns, J. G., 1975, Effects of glucagon and insulin on net hepatic metabolism of glucose precursors in sheep, Amer. J. Physiol. 229:1344.PubMedGoogle Scholar
  29. Bromer, W. W., 1976, Studies with glucagon analogs, Metabolism 25(Suppl.):1315.PubMedGoogle Scholar
  30. Bromer, W. W., Sinn, L. G., and Behrens, O. K., 1957, The amino acid sequence of glucagon. V. Location of amide groups, acid degradation studies, and summary of sequential evidence, J. Amer. Chem. Soc. 79:2807.Google Scholar
  31. Bromer, W. W., Boucher, M. E., and Koffenberger, J. E., Jr., 1971, Amino acid sequence of bovine glucagon,J. Biol. Chem. 246:2822.PubMedGoogle Scholar
  32. Brown, M., and Vale, W., 1976, Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels, Endocrinology 98:819.PubMedGoogle Scholar
  33. Brown, M., Villarreal, J., and Vale, W., 1976a, Neurotensin and substance P. Effects on plasma insulin and glucagon levels, Metabolism 25(Suppl.): 1459.Google Scholar
  34. Brown, M., Rivier, J., and Vale, W., 1976b, Somatostatin analogs with selected biologic activities, Metabolism 25(Suppl.):1501.Google Scholar
  35. Buchanan, K. D., and McCarroll, A. M., 1972, Abnormalities of glucagon metabolism in untreated diabetes mellitus, Lancet 2:1394.PubMedGoogle Scholar
  36. Cahill, G. F., Jr., 1971, Physiology of insulin in man (Banting Memorial Lecture), Diabetes 20:785.PubMedGoogle Scholar
  37. Cherrington, A. D., and Exton, J. H., 1976, Studies on the role of cAMP-dependent protein kinase in the actions of glucagon and catecholamines on liver glycogen metabolism, Metabolism 25(Suppl.):1351.PubMedGoogle Scholar
  38. Cherrington, A., and Vranic, M., 1974, Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depan-creatized dogs, Metabolism 23:729.PubMedGoogle Scholar
  39. Chiasson, J. L., Liljenquist, J. E., Sinclair-Smith, B. C., and Lacy, W. W., 1975, Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatorv effect of glucagon, Diabetes 24:574.PubMedGoogle Scholar
  40. Creutzfeldt, W., Raubisch, P. G., and Folsch, U.R., 1975, Hemmung der Sekretin-und Cholezystokinin-pankreozymin induzieken Saft- und Enzymsekretin des Pankreas und der gallenblasen Kontraktion beim Menschen durch Somatostatin, Dtsch. Med. Wochenschr. 100:1135.PubMedGoogle Scholar
  41. Danforth, D. N., Jr., Triche, T., Doppman, J. L., Beazley, R. M., Penino, P. V., and Recant, L., 1976, Elevated plasma proglucagon-like component with a glucagon-secreting tumor. Effect of streptozotocin, N. Engl. J. Med. 295:242.PubMedGoogle Scholar
  42. Dencker, H., Hedner, P., Holst, J., and Tranberg, K. G., 1975, Pancreatic glucagon response to an ordinary meal, Scand. J. Gastroenterol. 10:471.PubMedGoogle Scholar
  43. Dich, J., and Gluud, C. N., 1976, Effect of glucagon on cyclic AMP, albumin, metabolism and incorporation of 14C-leucine into proteins in isolated parenchymal rat liver cells, Acta Physiol. Scand. 97:457.PubMedGoogle Scholar
  44. Dobbs, R. E., Sakurai, H., Sasaki, H., Faloona, G. R., Valverde, I., Baetens, D., Orci, L., and Unger, R. H., 1975, Glucagon: Role in the hyperglycemia of diabetes mellitus, Science 187:544.PubMedGoogle Scholar
  45. Dobbs, R., Schusdziarra, V., Rivier, J., and Brown, M., 1977, Somatostatin analogs as glucagon suppressants in diabetes, Diabetes 26(Suppl.):360.Google Scholar
  46. Dubois, M. P., 1975, Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas, Proc. Natl. Acad. Sci. U.S.A. 72:1340.PubMedGoogle Scholar
  47. Duckworth, W. C., and Kitabchi, A. E., 1974, Insulin and glucagon degradation by the same enzyme, Diabetes 23:536.PubMedGoogle Scholar
  48. Eisenstein, A. B., and Strack, I., 1976, A nonsuppressible increase of glucagon secretion by isolated islets of high-protein-fed rats, Diabetes 25:51.PubMedGoogle Scholar
  49. Ensinck, J. W., and Palmer, J. P., 1976, Dominant inheritance of large molecular weight species of glucagon, Metabolism 25(Suppl.):1409.PubMedGoogle Scholar
  50. Epand, R. M., Cote, T. E., Hui Bon Hoa, D., Rosselin, G., and Schreier, S., 1976, Biologic activity and conformational properties of glucagon and glucagon analogs, Metabolism 25(Suppl.):13l7.Google Scholar
  51. Exton, J. H., and Park, C. R., 1969, Control of gluconeogenesis in liver. III. Effects of L-lactate, pyruvate, fructose, glucagon, epinephrine, and adenosine 3′,5′-monophosphate on gluconeogenic intermediates in the perfused rat liver, J.Biol. Chem. 244:1424.PubMedGoogle Scholar
  52. Faloona, G. R., 1972, The structure-function relationships of pancreatic glucagon, in: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications (P. J. Lefebvre and R. H. Unger, eds.), pp. 201–204, Pergamon Press, Oxford.Google Scholar
  53. Felig, P., Gusberg, R., Hendler, R., Gump, F. E., and Kinney, J. M., 1974, Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation (38286), Proc. Soc. Exp. Biol. Med. 147:88.PubMedGoogle Scholar
  54. Felig, P., Wahren, J., and Hendler, R., 1976, Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man,J. Clin. Invest. 58:761.PubMedGoogle Scholar
  55. Feliu, J. E., Hue, L., and Hers, H. G., 1976, Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes, Proc. Natl. Acad. Sci. U.S.A. 73:2762.PubMedGoogle Scholar
  56. Ferner, H., 1953, The A- and B-cells of the pancreatic islets as sources of the antagonistic hormones glucagon and insulin. The shift of the AB-relation in diabetes mellitus, Amer. J. Dig. Dis. 20:301.PubMedGoogle Scholar
  57. Fisher, M., Sherwin, R. S., Hendler, R., and Felig, P., 1976, Kinetics of glucagon in man: Effects of starvation, Proc. Natl. Acad. Sci. U.S.A. 73:1735.PubMedGoogle Scholar
  58. Frame, C. M., Davidson, M. B., and Sturdevant, R. A. L., 1975, Effects of the octapeptide of cholecystokinin on insulin and glucagon secretion in the dog, Endocrinology 97:549.PubMedGoogle Scholar
  59. Freinkel, N., and Goodner, C. J., 1960, Carbohydrate metabolism in pregnancy. I. The metabolism of insulin by human placental tissue,J. Clin. Invest. 39:116.PubMedGoogle Scholar
  60. Gabbay, K. H., DeLuca, K., Fisher, J. N., Jr., Mako, M. E., and Rubenstein, A. H., 1976, Familial hyperproinsulinemia: An autosomal dominant defect, N. Engl. J.Med. 294:911.PubMedGoogle Scholar
  61. Galbo, H., and Holst, J. J., 1976, The influence of glucagon on hepatic glycogen mobilization in exercising rats, Pfluegers Arch. 363:49.Google Scholar
  62. Galbo, H., Holst J. J., Christensen, N. J., and Hilsted, J., 1976, Glucagon and plasma catecholamines during beta-receptor blockade in exercising man, J. Appl. Physiol. 40:855.PubMedGoogle Scholar
  63. Ganda, O. P., Weir, G. C., Soeldner, J. S., Legg, M. A., Chick, W. L., Patel, Y. C., Ebeid, A. M., Gabbay, K. H., and Reichlin, S., 1977, Somatostatinoma: A somatostatin containing tumor of the endocrine pancreas, N. Engl. J. Med. 296:963.PubMedGoogle Scholar
  64. Gerich, J. E., 1976, Metabolic effects of longterm somatostatin infusion in man, Metabolism 25(Suppl.):1505.PubMedGoogle Scholar
  65. Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., and Forsham, P. H., 1973, Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect, Science 182:171.PubMedGoogle Scholar
  66. Gerich, J. E., Lorenzi, M., Karam, J. H., Schneider, V., and Forsham, P. H., 1975a, Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus,J. Amer. Med. Assoc. 234:159.Google Scholar
  67. Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., and Forsham, P. H., 1975b, Prevention of human diabetic ketoacidosis by somatostatin: Evidence for an essential role of glucagon, N. Engl. J. Med. 292:985.Google Scholar
  68. Gerich, J. E., Tsalikian, E., Lorenzi, M., Karam, J. H., Schneider, V., Gustafson, G., and Bohannon, N. V., 1975c, Normalization of fasting hyperglucagone-mia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin, J. Clin. Endocrinol, Metab. 41:1178.Google Scholar
  69. Gerich, J. E., Lorenzi, M., Tsalikian, E., and Karam, J. H., 1976a, Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion, Diabetes 25:65.Google Scholar
  70. Gerich, J. E., Langlois, M., Noacco, C., Lorenzi, M., Karam, J. H., and Forsham, P. H., 1976b, Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus,J. Clin. Invest. 58:320.Google Scholar
  71. Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V., Karam, J. H., and Forsham, P. H., 1976c, Effects of physiologic levels of glucagon and growth hormone of human carbohydrate and lipid metabolism: Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin,J. Clin. Invest. 57:875.Google Scholar
  72. Girard, J. R., Guillet, I., Marty, J., Assan, R., and Marliss, E. B., 1976, Effects of exogenous hormones and glucose on plasma levels and hepatic metabolism of amino acids in the fetus and in the newborn rat, Diabetologia 12:327.PubMedGoogle Scholar
  73. Girardier, L., Seydoux, J., and Campfield, L. A., 1976, Control of A and B cells in vivo by sympathetic nervous input and selective hyper- or hypoglycemia in dog pancreas,J. Physiol. (Paris) 72:801.Google Scholar
  74. Goldfine, I. D., and Smith, G. J., 1976, Binding of insulin to isolated nuclei, Proc. Natl. Acad. Sci. U.S.A. 73:1427.PubMedGoogle Scholar
  75. Goodner, C. J., Walike, B. C., Koerker, D. J., Brown, A. C., Ensinck, J. W., Chideckel, E. W., Palmer, J., and Kalnasy, L. W., 1976, Insulin, glucagon and glucose: Synchronous, stable oscillations in the Rhesus monkey, Diabetes 25(Suppl.):340.Google Scholar
  76. Hammes, G. G., and Rodbell, M., 1976, Simple model for hormone-activated adenylate cyclase systems, Proc. Natl. Acad. Sci. U.S.A. 73:1189.PubMedGoogle Scholar
  77. Harvey, W. D., Faloona, G. R., and Unger, R. H., 1974, The effect of adrenergic blockade on exercise-induced hyperglucagonemia, Endocrinology 94:1254.PubMedGoogle Scholar
  78. Heding, L. G., Frandsen, E. K., and Jacobsen, H., 1976, Structure-function relationship: Immunologic, Metabolism 25(Suppl.).1327.PubMedGoogle Scholar
  79. Hruby, V. J., Wright, D. E., Lin, M. C., and Rodbell, M., 1976, Semisynthetic glucagon derivatives for structure-function studies, Metabolism 25(Suppl.):1323.PubMedGoogle Scholar
  80. Hutson, N.J., Brumley, F. T., Assimacopoulos, F. D., Harper, S. C., and Exton, J. H., 1976, Studies on the alpha-adrenergic activation of hepatic glucose output. I. Studies on the alpha-adrenergic activation of Phosphorylase and gluconeogenesis and inactivation of glycogen synthase in isolated rat liver parenchymal cells,J. Biol Chem. 251:5200.PubMedGoogle Scholar
  81. Ipp, E., Patton, G., Dobbs, R., Harris, V., Vale, W., and Unger, R. H., 1977, Endogenous immunoreactive somatostatin (IRS) secretion by the pancreas, Diabetes 26:359.Google Scholar
  82. Ishida, T., Kawamura, K., Goto, A., Nishina, Y., Takahara, J., Yamamoto, S., Kawanishi, K., and Ofjui, T., 1976, Comparison studies of neurotensin and xenopsin upon pancreatic secretion in dog, Metabolism 25(Suppl.):1467.PubMedGoogle Scholar
  83. Ito, S., and Kobayashi, S., 1976, Immunohistochemical demonstration of glucagon- and GLI-containing cells in the canine gut and pancreas, Arch. Histol. Jpn. 39:193.PubMedGoogle Scholar
  84. Jaspan, J. B., Kuku, S. F., Locker, J. D., Huen, A. H.-J., Emmanouel, D. S., Katz, A. I., and Rubenstein, A. H., 1976, Heterogeneity of plasma glucagon in man, Metabolism 25(Suppl.):1397.PubMedGoogle Scholar
  85. Johnson, D. G., and Ensinck, J. W., 1976, Stimulation of glucagon secretion by scorpion toxin in the perfused rat pancreas, Diabetes 25:645.PubMedGoogle Scholar
  86. Kakiuchi, S., and Tomizawa, H. H., 1964, Properties of a glucagon-degrading enzyme of beef liver,J. Biol. Chem. 239:2160.PubMedGoogle Scholar
  87. Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J., and Gale, C. C., 1974, Somatostatin: Hypothalamic inhibitor of the endocrine pancreas, Science 184:482.PubMedGoogle Scholar
  88. Kuku, S. F., Jaspan, J. B., Emmanouel, D. S., Zeidler, A., Katz, A. I., and Rubenstein, A. H., 1976, Heterogeneity of plasma glucagon, circulating components in normal subjects and patients with chronic renal failure,J. Clin. Invest. 58:742.PubMedGoogle Scholar
  89. Larsson, L.-I., Holst, J., Häkanson, R., and Sundler, F., 1975, Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: An immunohistochemical and immunochemical study, Histochemistry 44:281.PubMedGoogle Scholar
  90. Larsson, L.-I., Hirsch, M. A., Holst, J. J., Ingemansson, S., Kuhl, C., Lindkaer Jensen, S., Lundqvist, G., Rehfeld, J. F., and Schwartz, T. W., 1977, Pancreatic somatostatinoma: Clinical features and physiological implications, Lancet 1:666.PubMedGoogle Scholar
  91. Lawrence, A. M., Tan, S., Hojvat, S., Kirsteins, L., and Mitton, J., 1976, Salivary gland glucagon in man and animals, Metabolism 25(Suppl.):1405.PubMedGoogle Scholar
  92. Leblanc, H., Rigg, L. A., and Yen, S. S., 1975, The response of pancreatic and pituitary hormones to pulses and constant infusion of somatostatin, J. Clin. Endocrinol. Metab. 41:1105.PubMedGoogle Scholar
  93. Leclercq-Meyer, V., Rebolledo, O., Marchano, J., and Malaisse, W., 1975, Glucagon release: Paradoxical stimulation by glucose during calcium deprivation, Science 189:897.PubMedGoogle Scholar
  94. Lefebvre, P. J., and Luyckx, A. S., 1972, Glucagon and catecholamines, in: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications (P. J. Lefebvre and R. H. Unger, eds.), pp. 175–180, Pergamon Press, Oxford.Google Scholar
  95. Lefebvre, P. J., and Luyckx, A. S., 1975, Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog, Metabolism 24:1169.PubMedGoogle Scholar
  96. Lefebvre, P. J., and Luyckx, A. S., 1976, Plasma glucagon after kidney exclusion: Experiments in somatostatin-infused and in eviscerated dogs, Metabolism 25:761.PubMedGoogle Scholar
  97. Liljenquist, J. E., Chiasson, J. L., Cherrington, A. D., Keller, U., Jennings, A. S., Bomboy, J. D., and Lacy, W. W., 1976, An important role for glucagon in the regulation of glucose production in vivo, Metabolism 25(Suppl.):1371.Google Scholar
  98. Lin, M. C., Nicosia, S., and Rodbell, M., 1976, Effects of iodination of tyrosyl residues on the binding and action of glucagon and its receptor, Biochemistry 15:4537.PubMedGoogle Scholar
  99. Lindsey, C. A., Santeusanio, F., Braaten, J., Faloona, G. R., and Unger, R. H., 1974a, Pancreatic alpha-cell function in trauma, J. Amer. Med. Assoc. 227:757.Google Scholar
  100. Lindsey, C. A., Faloona, G. R., and Unger, R. H., 1974b, Plasma glucagon in nonketotic hyperosmolar coma,J. Amer. Med. Assoc. 229:1771.Google Scholar
  101. Luft, R., Efendic, S., Hökfelt, T., Johansson, Ü., and Arimura, A., 1974, Immunohistochemical evidence for the localization of somatostatin-like immunoreactivity in a cell population of the pancreatic islets, Med. Biol. 52:428.PubMedGoogle Scholar
  102. Lundquist, I., Fanska, R., and Grodsky, G. M., 1976a, Direct calcium-stimulated release of glucagon from the isolated perfused rat pancreas and the effect of chemical sympathectomy, Endocrinology 98:815.Google Scholar
  103. Lundquist, I., Fanska, R., and Grodsky, G., 1976b, Interaction of calcium and glucose on glucagon secretion, Endocrinology 99:1304.Google Scholar
  104. Luyckx, A. S., and Lefebvre, P. J., 1972, Role of catecholamines in exercise-induced glucagon secretion in rats, Diabetes 21(Suppl.):334.Google Scholar
  105. Mackrell, D. J., and Sokal, J. E., 1969, Antagonism between the effects of insulin and glucagon on the isolated liver, Diabetes 18:724.PubMedGoogle Scholar
  106. Madison, L. L., Seyffert, W. A., Jr., Unger, R. H., and Baker, B., 1968, Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations, Metabolism 17:301.PubMedGoogle Scholar
  107. Mallinson, C. N., Bloom, S. R., Warin, A. P., Salmon, P. R., and Cox, B., 1974, A glucagonoma syndrome, Lancet 2:1.PubMedGoogle Scholar
  108. Marco, J., Calle, C., Roman, D., Diaz-Fierros, M., Villanueva, M. L., and Valverde, I., 1973, Hyperglucagonism induced by glucocorticoid treatment in man, N. Engl. J. Med. 288:128.PubMedGoogle Scholar
  109. Marco, J., Calle, C., Hedo, J. A., and Villanueva, M. L., 1976, Enhanced glucagon secretion by pancreatic islets from prednisolone-treated mice, Diabetologia 12:307.PubMedGoogle Scholar
  110. Markussen, J., Frandsen, E., Heding, L. G., and Sundby, F., 1972, Turkey glucagon: Crystallization, amino acid composition, and immunology, Horm. Metab. Res. 4:360.PubMedGoogle Scholar
  111. Marliss, E. B., Girardier, L., Seydoux, J., Wollheim, C. B., Kanazawa, Y., Orci, L., Renold, A. E., and Porte, D., Jr., 1973, Glucagon release induced by pancreatic nerve stimulation in the dog,J. Clin. Invest. 52:1246.PubMedGoogle Scholar
  112. Mashiter, K., Harding, P. E., Chou, M., Mashiter, G. D., Stout, J., Diamond, D., and Field, J. B., 1975, Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs, Endocrinology 96:678.PubMedGoogle Scholar
  113. Matschinsky, F. M., Pagliara, A. S., Hover, B. A., Havmond, M. W., and Stillings, S. N., 1975, Differential effects of alpha- and beta-D-glucose on insulin and glucagon secretion from the isolated perfused rat pancreas, Diabetes 24:369.PubMedGoogle Scholar
  114. Matschinsky, F. M., Pagliara, A. S., Sailings, S. N., and Hover, B. A., 1976, Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats,J. Clin. Invest. 58:1193.PubMedGoogle Scholar
  115. Matsuyama, T., and Foa, P. P., 1975, Plasma glucose, insulin, pancreatic and enteroglucagon levels in normal and depancreatized dogs (38288), Proc. Soc. Exp. Biol. Med. 147:97.Google Scholar
  116. McGarry, J. D., Robles-Valdes, C., and Foster, D. W., 1976, Glucagon and keto-genesis, Metabolism 25(Suppl.):1387.PubMedGoogle Scholar
  117. McGavran, M. H., Unger, R. H., Recant, L., Polk, H. C., Kilo, C., and Levin, M. E., 1966, A glucagon-secreting alpha cell carcinoma of the pancreas, N. Engl. J. Med. 274:1408.PubMedGoogle Scholar
  118. Meissner, H. P., 1976, Electrophysiological evidence for coupling between B-cells of pancreatic islets, Nature (London) 262:502.Google Scholar
  119. Metzger, B. E., Unger, R. H., and Freinkel, N., 1977, Carbohydrate metabolism in pregnancy. XVI. Relationships between circulating glucagon, insulin, glucose and amino acids in response to a “mixed meal” in late pregnancy, Metabolism 26:151.PubMedGoogle Scholar
  120. Miller, L. L., 1976, Direct effects of glucagon on protein and amino acid metabolism in the isolated perfused rat liver. Interactions with insulin and dexameth-asone in net synthesis of albumin and acute-phase proteins, Diabetes 25(Suppl.):865.PubMedGoogle Scholar
  121. Miyata, M., Yamamoyo, T., Yamaguchi, M., Nakao, K., and Yoshida, T., 1976, Plasma glucagon alter total resection of the pancreas in man (39435), Proc. Soc. Exp. Biol. Med. 152:510.Google Scholar
  122. Moody, A. J., Frandsen, E. K., Jacobsen, H., Sundby, F., and Orci, L., 1976, Discussion, Metabolism 25(Suppl.):1336.Google Scholar
  123. Mortimer, C. H., Turnbridge, W. M. G., Carr, D., Yeomans, L., Lind, T., Coy, D. H., Bloom, S. R., Kastin, A., Mallinson, C. N., Besser, G. M., Schally, A. V., and Hall, R., 1974, Effects of growth hormone release-inhibiting hormone on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic and hypopituitary patients, Lancet 1:697.PubMedGoogle Scholar
  124. Müller, W. A., Faloona, G. R., Unger, R. H., and Aguilar-Parada, E., 1970, Abnormal alpha cell function in diabetes. Response to carbohydrate and protein ingestion, N. Engl. J. Med. 283:109.PubMedGoogle Scholar
  125. Müller, W. A., Faloona, G. R., and Unger, R. H., 1971, The effect of experimental insulin deficiency on glucagon secretion,J. Clin. Invest. 50:1992.PubMedGoogle Scholar
  126. Müller, W. A., Faloona, G. R., and Unger, R. H., 1973, Hyperglucagonemia in diabetic ketoacidosis: Its prevalence and significance, Amer. J. Med. 54:52.PubMedGoogle Scholar
  127. Munoz-Barragan, L., Rufener, C., Srikant, C. B., Dobbs, R. E., Shannon, W. A., Baetens, D., and Unger, R. H., 1977, Immunocytochemical evidence for glucagon-containing cells in the human stomach, Horm. Metab. Res. 9:37.PubMedGoogle Scholar
  128. Nagai, K., and Frohman, L. A., 1976, Hyperglycemia and hyperglucagonemia following neurotensin administration, Life Sci. 19:273.PubMedGoogle Scholar
  129. Nakabayashi, H., Yoshimitsu, K., Kishitani, M., Ueda, M., and Kawato, M., 1976, Effect of somatostatin on pancreatic endocrine—Experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs, Folia Endocrinol. Jpn. 52:218.Google Scholar
  130. Noe, B. D., 1976, Biosynthesis of glucagon, Metabolism 25(Suppl.):1339.PubMedGoogle Scholar
  131. Noe, B. D., and Bauer, G. E., 1971, Evidence for glucagon biosynthesis involving a protein intermediate in islets of the anglerfish (Lophius americanus), Endocrinology 89:642.PubMedGoogle Scholar
  132. Noe, B. D., Bauer, G. E., Steffes, M. W., Sutherland, D. E. R., and Najarian, J. S., 1975, Glucagon biosynthesis in human pancreatic islets: Preliminary evidence for a biosynthetic intermediate, Horm. Metab. Res. 7:314.PubMedGoogle Scholar
  133. O’Connor, K. J., and Lazarus, N. R., 1976, Studies on the biosynthesis of pancreatic glucagon in the pigeon (Columba livia), Biochem. J. 156:279.PubMedGoogle Scholar
  134. Orci, L., 1976, The microanatomy of the islets of Langerhans, Metabolism 25(Suppl.):1303.PubMedGoogle Scholar
  135. Orci, L., 1977, Discussion, in: Recent Progress in Hormone Research, Vol. 33 (R. O. Greep, ed.). Academic Press, New York.Google Scholar
  136. Orci, L., and Unger, R. H., 1975, Functional subdivision of islets of Langerhans and possible role of D-cells, Lancet 2:1243.PubMedGoogle Scholar
  137. Orci, L., Pictet, R., Forssmann, W. G., Renold, A. E., and Rouiller, C., 1968, Structural evidence for glucagon producing cells in the intestinal mucosa of the rat, Diabetologia 4:56.PubMedGoogle Scholar
  138. Orci, L., Unger, R. H., and Renold, A. E., 1973, Structural coupling between pancreatic islet cells, Experientia 29:1015.PubMedGoogle Scholar
  139. Orci, L., Baetens, D., Dubois, M. P., and Rufener, C., 1975a, Evidence for the D-cell of the pancreas secreting somatostatin, Horm. Metab. Res. 7:400.Google Scholar
  140. Orci, L., Malaisse-Lagae, F., Amherdt, M., Ravazzola, M., Weisswange, A., Dobbs, R., Perrelet, A., and Unger, R., 1975b, Cell contacts in human islets of Langerhans,J. Clin. Endocrinol. Metab. 41:841.Google Scholar
  141. Orci, L., Malaisse-Lagae, F., Ravazzola, M., Rouiller, D., Renold, A. E., Perrelet, A., and Unger, R. H., 1975c, A morphological basis for intercellular communication between A- and B-cells in the endocrine pancreas, J. Clin. Invest. 56:1066.Google Scholar
  142. Orci, L., Baetens, D., Rufener, C., Amherdt, M., Ravazzola, M., Studer, P., Malaisse-Lagae, F., and Unger, R. H., 1976, Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes, Proc. Natl. Acad. Sci. U.S.A. 73:1338.PubMedGoogle Scholar
  143. Palmer, J. P., Werner, P. L., Benson, J. W., and Ensinck, J. W., 1976, Immuno-reactive glucagon responses to arginine in three pancreatectomized humans, Metabolism 25(Suppl.):1483.PubMedGoogle Scholar
  144. Parrilla, R., Jimenez, L., and Ayuso-Parrilla, M. S., 1975, Glucagon and insulin control in gluconeogenesis in the perfused isolated rat liver. Effects on cellular metabolite distribution, Eur. J. Biochem. 56:375.Google Scholar
  145. Park, C. R., and Exton, J. H., 1972, Glucagon and the metabolism of glucose, in: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications (P. J. Lefebvre and R. H., Unger, eds.), pp. 77–108, Pergamon Press, Oxford.Google Scholar
  146. Patel, Y. C., Orci, L., Bankier, A., and Cameron, D. P., 1976, Decreased pancreatic somatostatin (SRIF) concentration in spontaneously diabetic mice, Endocrinology 99:1415.PubMedGoogle Scholar
  147. Patton, G., Brown, M., Dobbs, R., Vale, W., and Unger, R. H., 1976a, Effects of neurotensin and substance P on insulin and glucagon release by the perfused dog pancreas, Metabolism 25(Suppl.):1465.Google Scholar
  148. Patton, G. S., Dobbs, R., Orci, L., Vale, W., and Unger, R. H., 1976b, Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon, Metabolism 25(Suppl.):1499.Google Scholar
  149. Patton, G. S., Ipp, E., Dobbs, R. E., Vale, W., Orci, L., and Unger, R. H., 1976c, Response of pancreatic immunoreactive somatostatin to arginine, Life Sci. 19:1957.Google Scholar
  150. Patton, G. S., Ipp, E., Dobbs, R. E., Orci, L., Vale, W., and Unger, R. H., 1977, Pancreatic immunoreactive somatostatin release, Proc. Natl. Acad. Sci U.S.A. 74:2140.PubMedGoogle Scholar
  151. Pek, S., Tai, T. Y., Elster, A., and Fajans, S. S., 1975, Stimulation by prostaglandin E2 of glucagon and insulin release from isolated rat pancreas, Prostaglandins 10:493.PubMedGoogle Scholar
  152. Pelletier, G., Leclerc, R., Arimura, A., and Schally, A. V., 1975, Immunohistochemical localization of somatostatin in the rat pancreas, J. Histochem. Cytochem. 23:699.PubMedGoogle Scholar
  153. Penhos, J. C., Ezequiel, M., Lepp, A., and Ramey, E. R., 1975, Plasma immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) after evisceration with and without a functional liver, Diabetes 24:637.PubMedGoogle Scholar
  154. Permutt, M. A., Delmez, J., and Stenson, W., 1976, Effects of carbohydrate restriction on the hypoglycemic phase of the glucose tolerance test, J. Clin. Endocrinol. Metab. 43:1088.PubMedGoogle Scholar
  155. Petersson, B., and Hellman, B., 1963, Effects of long-term administration of glucagon on the pancreatic islet tissue of rats and guinea pigs, Acta Endocrinol. 44:139.PubMedGoogle Scholar
  156. Pilkis, S. J., Claus, T. H., Riou, J. P., and Park, C. R., 1976, Possible role of pyruvate kinase in the hormonal control of dihydroxyacetone gluconeogenesis in isolated hepatocytes, Metabolism 25(Suppl.):1355.PubMedGoogle Scholar
  157. Polak, J. M., Pearse, A. G. E., Grimelius, L., Bloom, S. R., and Arimura, A., 1975, Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D-cells, Lancet 1:1220.PubMedGoogle Scholar
  158. Pollock, H. G., and Kimmel, J. R., 1975, Chicken glucagon: Isolation and amino acid sequence studies,J. Biol. Chem. 250:9377.PubMedGoogle Scholar
  159. Porte, D., Jr., Woods, S. C., Chen, M., Smith, P. H., and Ensinck, J. W., 1975, Central factors in the control of insulin and glucagon secretion, Pharmacol. Biochem. Behav. 3:127.PubMedGoogle Scholar
  160. Rabinovitch, A., and Dupre, J., 1974, Effects of gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat, Endocrinology 94:1139.PubMedGoogle Scholar
  161. Raskin, P., and Unger, R. H., 1977, Effects of hyperglucagonemia in well controlled insulin-treated diabetics Diabetes (in press).Google Scholar
  162. Raskin, P., Fujita, Y., and Unger, R. H., 1975, Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics, J. Clin. Invest. 56:1132.PubMedGoogle Scholar
  163. Raskin, P., Aydin, I., and Unger, R. H., 1976, The effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus, Diabetes 25:227.PubMedGoogle Scholar
  164. Recant, L., Perrino, P. V., Bhathena, S. J., Danfort, D. N., Jr., and Levine, R. L., 1976, Plasma immunoreactive glucagon fractions in four cases of glucagonoma: Increased “large glucagon immunoreactivity,” Diabetologia 12:319.PubMedGoogle Scholar
  165. Rigopoulou, D., Valverde, I., Marco, J., Faloona, G., and Unger, R. H., 1970, Large glucagon immunoreactivity in extracts of pancreas, J. Biol. Chem. 245:496.PubMedGoogle Scholar
  166. Rivier, J. E., Brown, M. R., and Vale, W. W., 1976, Tyrosylated analogues of somatostatin,J. Med. Chem. 19:1010.PubMedGoogle Scholar
  167. Rocha, D. M., Faloona, G. R., and Unger, R. H., 1972, Glucagon stimulating activity of twenty amino acids in dogs, J. Clin. Invest. 51:2346.Google Scholar
  168. Rocha, D. M., Santeusanio, F., Faloona, G. R., and Unger, R. H., 1973, Abnormal pancreatic alpha-cell function in bacterial infections, N. Engl. J. Med. 288:700.PubMedGoogle Scholar
  169. Rodbell, M., and Londos, C., 1976, Regulation of hepatic adenylate cyclase by glucagon, GTP, divalent cations, ana adenosine, Metabolism 25(Suppl.): 1347.PubMedGoogle Scholar
  170. Sacks, H., Waligora, K., Matthews, J., and Pimstone, B., 1977, Inhibition by somatostatin of glucagon-induced glucose release from the isolated perfused rat liver, Diabetes 26:358.Google Scholar
  171. Sakurai, H., Dobbs, R., and Unger, R. H., 1974, Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs, J. Clin. Invest. 54:1395.PubMedGoogle Scholar
  172. Sakurai, H., Dobbs, R. E., and Unger, R. H., 1975a, The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein and fat, Diabetologia 11:427.Google Scholar
  173. Sakurai, H., Dobbs, R. E., and Unger, R. H., 1975b, The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus, Metabolism 24:1287.Google Scholar
  174. Samols, E., and Harrison, J., 1976, Remarkable potency of somatostatin as a glucagon suppressant, Metabolism 25(Suppl.):1495.PubMedGoogle Scholar
  175. Samols, E., Marri, G., and Marks, V., 1965, Promotion of insulin secretion by glucagon, Lancet 2:415.PubMedGoogle Scholar
  176. Samols, E., Tyler, J., and Marks, V., 1972, Glucagon-insulin interrelationships, in: Glucagon: Molecular Physiology, Clinical and Therapeutic Implications (P. J. Lefebvre and R. H. Unger, eds.), pp. 151–174, Pergamon Press, Oxford.Google Scholar
  177. Samols, E., Weir, G. C., Patel, Y. C., Fernandez-Durango, R., Arimura, A., and Loo, S. W., 1977, Suppression of canine pancreatic A, B, D and PP cell secretion bv diazoxide, Diabetes 26(Suppl.):375.Google Scholar
  178. Sasagawa, T., Kobayashi, S., and Fujita, T., 1973, Electron microscopy studies on the GEP endocrine cells of the human gut and pancreas, in: Gastro-Entero-Pancreatic Endocrine System (T. Fujita, ed.), pp. 17–38, Igaku Shoin, Tokyo.Google Scholar
  179. Sasaki, H., Rubalcava, B., Baetens, D., Blazquez, E., Srikant, C. B., Orci, L., and Unger, R. H., 1975a, Identification of glucagon in the gastrointestinal tract, J. Clin. Invest. 56:135.Google Scholar
  180. Sasaki, H., Rubalcava, B., Srikant, C. B., Baetens, D., Orci, L., and Unger, R. H., 1975b, Gut glucagonoid (GLI) and gut glucagon, in: Gastrointestinal Hormones (J. C. Thompsen, ed.), pp. 519–528, University of Texas Press, Austin.Google Scholar
  181. Schauder, P., Mcintosh, C., Arends, J., Arnold, R., Frerichs, H., and Creutzfeldt, W., 1976, Somatostatin and insulin release from isolated rat pancreatic islets’ stimulated by glucose, FEBS Lett. 68:225.PubMedGoogle Scholar
  182. Schebalin, M., Said, S. I., and Makhlouf, G. M., 1977, Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide, Amer. J. Physiol. 232: E197.PubMedGoogle Scholar
  183. Schusdziarra, V., Ipp, E., and Unger, R. H., 1977, Somatostatin, a physiologic regulator of nutrient influx, Diabetes 26(Suppl.):359.Google Scholar
  184. Seitz, H. J., Muller, M. J., Nordmeyer, P., Krone, W., and Tarnowski, W., 1976, Concentration of cyclic AMP in rat liver as a function of the insulin/glucagon ratio in blood under standardized physiological conditions, Endocrinology 99:1313.PubMedGoogle Scholar
  185. Service, F. J., Molnar, G. D., Rosevear, J. W., Ackerman, E., Gatewood, L. C., and Taylor, W. F., 1970, Mean amplitude of glycemiv excursions, a measure of diabetic instability, Diabetes 19:644.PubMedGoogle Scholar
  186. Sherwin, R. S., Fisher, M., Hendler, R., and Felig, P., 1976, Hyperglucagonemia and blood glucose regulation in normal, obese, and diabetic subjects, N. Engl. J. Med 294:455.PubMedGoogle Scholar
  187. Sherwin, R. S., Hendler, R., Defronzo, R., Wahren, J., and Felig, P., 1977, Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin, Proc. Natl. Acad. Sci. U.S.A. 74:348.PubMedGoogle Scholar
  188. Soeters, P. B., and Fischer, J. E., 1976, Insulin, glucagon, amino acid imbalance, and hepatic encephalopathy, Lancet 2:880.PubMedGoogle Scholar
  189. Sperling, M. A., Grajwer, L. A., Leake, R., and Fisher, D. A., 1976, Role of glucagon in perinatal glucose homeostasis, Metabolism 25(Suppl.):1385.PubMedGoogle Scholar
  190. Srikant, C. B., and Unger, R. H., 1976, Evidence for the presence of glucagon-like immunoreactivity (GLI) in the pancreas, Endocrinology 99:1655.PubMedGoogle Scholar
  191. Srikant, C. B., McCorkle, K., and Unger, R. H., 1977, Properties of immunoreactive glucagon fractions of canine stomach and pancreas, J. Biol. Chem. 252: 1847.PubMedGoogle Scholar
  192. Staehelin, L. A., 1974, Structure and function of intercellular junctions, Int. Rev. Cytol. 39:191.PubMedGoogle Scholar
  193. Sundby, F., 1976, Species variations in the primary structure of glucagon, Metabolism 25(Suppl.):1319.PubMedGoogle Scholar
  194. Sundby, F., and Markussen, J., 1971, Isolation, crystallization, and amino acid composition of rat glucagon, Horm. Metab. Res. 3:184.PubMedGoogle Scholar
  195. Sundby, F., and Markussen, J., 1972, Rabbit glucagon: Isolation, crystallization, and amino acid composition, Horm. Metab. Res. 4:56.PubMedGoogle Scholar
  196. Sundby, F., Frandsen, E. K., Thomsen, J., Kristiansen, K., and Brundfeldt, K., 1972, Crystallization and amino acid sequence of duck glucagon, FEBS Lett. 26:289.PubMedGoogle Scholar
  197. Sundby, F., Jacobsen, H., and Moody, A. J., 1976, Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity, Horm. Metab. Res. 8:366.PubMedGoogle Scholar
  198. Sutherland, E. W., and DeDuve, C., 1948, Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas,J. Biol. Chem. 175:663.PubMedGoogle Scholar
  199. Tager, H. S., and Markese, J., 1976, Immunoreactive glucagon in pancreatic islets, Metabolism 25(Suppl.):1343.PubMedGoogle Scholar
  200. Tager, H. S., and Steiner, D. F., 1973, Isolation of a glucagon-containing peptide: Primary structure of a possible fragment of proglucagon, Proc. Natl. Acad. Sci. U.S.A. 70:2321.PubMedGoogle Scholar
  201. Tai, T. Y., and Pek, S., 1976, Direct stimulation by growth hormone of glucagon and insulin release from isolated rat pancreas, Endocrinology 99:669.PubMedGoogle Scholar
  202. Thomsen, J., Kristiansen, K., Brunfeldt, K., and Sundby, F., 1972, The amino acid sequence of human glucagon, FEBS Lett. 21:315.PubMedGoogle Scholar
  203. Tiengo, A., Fedele, D., Marchiori, E., Nosadini, R., and Muggeo, M., 1976, Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin and gastrin, Diabetes 25:408.PubMedGoogle Scholar
  204. Unger, R. H., 1971a, Glucagon physiology and pathophysiology, N. Engl. J. Med. 285:443.Google Scholar
  205. Unger, R. H., 1971b, Glucagon and the insulin:glucagon ratio in diabetes and other catabolic illnesses, Diabetes 20:834.Google Scholar
  206. Unger, R. H., 1976, Diabetes and the alpha cell (Banting Memorial Lecture), Diabetes 25:136.PubMedGoogle Scholar
  207. Unger, R. H., 1977, Editorial: Somatostatinoma, N. Engl. J. Med. 296:998.PubMedGoogle Scholar
  208. Unger, R. H., and Orci, L., 1975, The essential role of glucagon in the pathogenesis of diabetes mellitus, Lancet 1:14.PubMedGoogle Scholar
  209. Unger, R. H., and Orci, L., 1977, Possible roles of the pancreatic D-cell in the normal and diabetic states. Diabetes 26:241.PubMedGoogle Scholar
  210. Unger, R. H., Ketterer, H., Dupre, J., and Eisentraut, A. M., 1967, The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs,J. Clin. Invest. 46:630.PubMedGoogle Scholar
  211. Unger, R. H., Ohneda, A., Valverde, I., Eisentraut, A. M., and Exton, J., 1968, Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose,J. Clin. Invest. 47:48.PubMedGoogle Scholar
  212. Unger, R. H., Ohneda, A., Aguilar-Parada, E., and Eisentraut, A. M., 1969, The role of aminogenic glucagon secretion in blood glucose homeostasis, J. Clin. Invest. 48:810.PubMedGoogle Scholar
  213. Unger, R. H., Aguilar-Parada, E., Müller, W. A., and Eisentraut, A. M., 1970, Studies of pancreatic alpha cell function in normal and diabetic subjects, J. Clin. Invest. 49:837.PubMedGoogle Scholar
  214. Unger, R. H., Madison, L. L., and Müller, W. A., 1972, Abnormal alpha cell function in diabetics: Response to insulin, Diabetes 21:301.Google Scholar
  215. Unger, R. H., Aydin, I., Nakabayashi, H., Srikant, C. B., and Raskin, P., 1976, The effects of glucagon administration to nondiabetics and diabetics, Metabolism 25(Suppl.):1523.PubMedGoogle Scholar
  216. Unger, R. H., Raskin, P., Srikant, C. B., and Orci, L., 1977, Glucagon and the A-cells, in: Recent Progress in Hormone Research, Vol. 33 (R. O. Greep, ed.), pp. 477–517, Academic Press, New York.Google Scholar
  217. Vale, W., Ling, N., Rivier, J., Villarreal, J., Rivier, C., Brown, M., and Douglas, C., 1976, Anatomic and phylogenetic distribution of somatostatin, Metabolism 25(Suppl.):1491.PubMedGoogle Scholar
  218. Valverde, I., Rigopoulou, D., Marco, J., Faloona, G. R., and Unger, R. H., 1970, Molecular size of extractable glucagon and glucagon-like immunoreactivity (GLI) in plasma, Diabetes 19:624.PubMedGoogle Scholar
  219. Valverde, I., Villanueva, M. L., Lozano, I., and Marco, J., 1974, Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“big plasma glucagon”).J. Clin. Endocnnol. Metab. 39:1090.Google Scholar
  220. Valverde, L., Dobbs, R., and Unger, R. H., 1975, Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan diabetic dogs, Metabolism 24:1021.PubMedGoogle Scholar
  221. Valverde, L., Lemon, H. M., Kessinger, A., and Unger, R. H., 1976, Distribution of plasma glucagon immunoreactivity in a patient with a suspected glucagonoma, J. Clin. Endocrinol. Metab. 42:804.PubMedGoogle Scholar
  222. Veneziale, C. M., Deering, N. G., and Thompsen, H. J., 1976, Gluconeogenesis in isolated rat hepatic parenchymal cells. IX. Differential effects of glucagon and epinephrine on phosphofructokinase and pyruvate kinase, Mayo Clin. Proc. 51:624.PubMedGoogle Scholar
  223. Vranic, M., Pek, S., and Kawamori, R., 1974, Increased “glucagon immunoreactivity” in plasma of totally depancreatized dogs, Diabetes 23:905.PubMedGoogle Scholar
  224. Vranic, M., Engerman, R., Doi, K., Morita, S., and Yip, C. C., 1976, Extrapancreatic glucagon in the dog, Metabolism 25(Suppl.):1469.PubMedGoogle Scholar
  225. Wahren, J., and Felig, P., 1976, Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus, Lancet 2:1213.PubMedGoogle Scholar
  226. Wahren, J., Felig, P., and Hagenfeldt, L., 1976, Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus,J. Clin. Invest. 57:987.PubMedGoogle Scholar
  227. Weir, G. C., Turner, R. C., and Martin, D. B., 1973, Glucagon radioimmunoassay using antiserum 30K: Interference by plasma, Horm. Metab. Res. 5:241.PubMedGoogle Scholar
  228. Weir, G. C., Knowlton, S. D., Atkins, R. F., McKennan, K. X., and Martin, D. B., 1976, Glucagon secretion from the perfused pancreas of streptozotocin-treated rats, Diabetes 25:275.PubMedGoogle Scholar
  229. Weir, G. C., Samols, E., Ramseur, R., Day, J. A., Jr., and Patel, Y. C., 1977, Influence of glucose and glucagon upon somatostatin secretion from the isolated perfused canine pancreas, Clin. Res. 25:403A.Google Scholar
  230. Werner, P., and Palmer, J., 1977, The role of immunoreactive glucagon (IRG) in the control of plasma glucose in pancreatectomized (Px) man, Diabetes 26(Suppl.):383.Google Scholar
  231. Wilmore, D. W., Lindsey, C. A., Moylan, J. A., Faloona, G. R., Pruitt, B. A., and Unger, R. H., 1974, Hyperglucagonemia after burns, Lancet 1:73.PubMedGoogle Scholar
  232. Wise, J. K., Hendler, R., and Felig, P., 1973, Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man, J. Clin. Invest. 52:2774.PubMedGoogle Scholar
  233. Wollheim, C. B., Blondel, B., Renold, A. E., and Sharp, G. W., 1976a, Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium, Diabetologia 12:269.Google Scholar
  234. Wollheim, C. B., Blondel, B., Renold, A. E., and Sharp, G. W., 1976b, Calcium induced glucagon release in monolayer culture of the endocrine pancreas. Studies with ionophore A23187, Diabetologia 12:287.Google Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Roger H. Unger
    • 1
    • 2
  1. 1.Veterans Administration HospitalDallasUSA
  2. 2.Department of Internal MedicineThe University of Texas Southwestern Medical SchoolDallasUSA

Personalised recommendations